Skip to main content
. 2012 Sep 18;12:95. doi: 10.1186/1471-2377-12-95

Figure 2.

Figure 2

Th2/Th1 ratio in GA and NAT patients. Comparative Th2/Th1 ratios considering anti-inflammatory IL-4, IL-5, IL-6, IL-10 cytokines and pro-inflammatory cytokine INF-γ (A) or TNF-α (B). Box and whiskers plots showing median and interquartile ranges are presented. IL-4/IFN-γ, IL-4/TNF-α and IL-10/IFN-γ ratio as markers of Th2/Th1 ratio are significantly higher for GA patients compared to patients receiving NAT. *p < 0.05. GA = glatiramer acetate; NAT = natalizumab.